viernes, 23 de mayo de 2025

Benefits Persist With Inavolisib in PIK3CA-Mutated Breast Cancer Kate Johnson May 23, 2025 ++++++

https://www.medscape.com/viewarticle/benefits-persist-inavolisib-pik3ca-mutated-breast-cancer-2025a1000d1x New ASCO AI Tool Promises Fast, Accurate Guidelines Access Sharon Worcester, MA May 23, 2025 https://www.medscape.com/viewarticle/new-asco-ai-tool-promises-fast-accurate-guidelines-access-2025a1000d1m FDA Questions Value of Single-Arm Studies for Cancer Approvals M. Alexander Otto, PA, MMS May 23, 2025 https://www.medscape.com/viewarticle/fda-questions-value-single-arm-studies-cancer-approvals-2025a1000d1h Conference MDAngle: ASCO 2025 Prostate Cancer May 22, 2025 https://www.medscape.com/viewarticle/mdangle-asco-2025-prostate-cancer-overview-poll-2025a10000is ASCO 2025: Anticipating Key Innovations in Prostate Cancer Petros Grivas, MD, PhD https://www.medscape.com/viewarticle/mdangle-asco-2025-prostate-cancer-preconference-thoughts-2025a10000f0 Conference MDAngle: ASCO 2025 Early Breast Cancer May 22, 2025 https://www.medscape.com/viewarticle/mdangle-asco-2025-early-breast-cancer-overview-poll-2025a10002ju | May 22, 2025

No hay comentarios:

Publicar un comentario